OCTAVE SPECIALTY GROUP INC
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
OSG$5.41+2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows (Unaudited)
| Six Months Ended June 30, | ||
|---|---|---|
| (Dollars in thousands) | 2026 | 2025 |
| Cash flows from operating activities: | ||
| Net income (loss) | $(15,019) | $(117,690) |
| Net income (loss) from discontinued operations | — | (82,398) |
| Net income (loss) from continuing operations | (15,019) | (35,292) |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
| Intangible amortization and depreciation | 24,478 | 18,917 |
| Share-based compensation | 8,875 | 16,932 |
| Deferred tax provision (benefit) | (5,028) | (5,565) |
| Unearned premiums, net | 13,841 | 1,332 |
| Reinsurance recoverable and loss and loss adjustment expense, net | (20,508) | (35,349) |
| Ceded premiums payable | 12,785 | 37,555 |
| Premium and commissions receivables | (33,962) | (32,231) |
| Commissions payable | 13,057 | 25,444 |
| Contract assets and contract liabilities, net | (15,398) | (7,572) |
| Corporate costs reallocated to continuing operations | — | 5,265 |
| Other, net | (3,431) | 101 |
| Net cash provided by (used in) operating activities from continuing operations | (20,310) | (10,463) |
| Cash flows from investing activities: | ||
| Proceeds from sales of bonds | 40 | — |
| Proceeds from matured bonds | 25,214 | 21,816 |
| Purchases of bonds | (38,567) | (22,747) |
| Purchases of other investments | (147) | (66) |
| Proceeds from short-term investments, net | 63,928 | 24,966 |
| Other, net | (2,453) | (5,939) |
| Net cash provided by (used in) investing activities from continuing operations | 48,015 | 18,030 |
| Cash flows from financing activities: | ||
| Proceeds from long-term debt | 39,089 | — |
| Payments for purchases of common stock held in treasury | — | (3,301) |
| Payments for long-term debt | (1,500) | — |
| Tax payments related to shares withheld for share-based compensation plans | (583) | (1,516) |
| Payments to purchase warrants | (4,855) | — |
| Distributions to noncontrolling interest holders | (4,520) | (894) |
| Acquisitions of noncontrolling interest shares | (44,027) | (4,036) |
| Net cash provided by (used in) financing activities from continuing operations | (16,396) | (9,747) |
| Effect of foreign exchange on cash and cash equivalents - continuing operations | (653) | 1,288 |
| Net cash provided by (used in) continuing operations | 10,656 | (892) |
| Cash, cash equivalents, and restricted cash at beginning of period - continuing operations | 68,440 | 47,275 |
| Cash, cash equivalents, and restricted cash at end of period - continuing operations | $79,096 | $46,383 |
| Net cash provided by (used in) operating activities from discontinued operations | — | 34,851 |
| Net cash provided by (used in) investing activities from discontinued operations | — | 57,667 |
| Net cash provided by (used in) financing activities from discontinued operations | — | (94,854) |
| Effect of foreign exchange on cash and cash equivalents - discontinued operations | — | 475 |
| Net cash provided by (used in) discontinued operations | — | (1,861) |
| Cash, cash equivalents, and restricted cash at beginning of period - discontinued operations | — | 66,077 |
| Cash, cash equivalents, and restricted cash at end of period - discontinued operations | $— | $64,216 |
| Cash paid during the period for: | ||
| Interest on debt | $5,868 | $12,361 |
| Income taxes | $3,713 | $2,689 |
| Octave Specialty Group, Inc. | 6 | Second Quarter 2026 Form 10-Q |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.